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Hypertension is reported to complicate about 7–13% of all 
pregnancies and it represents the most common medical disor-
der of pregnancy.1 Preeclampsia (PE) affects 2–5% of pregnan-
cies in developed countries2 and is a major cause of maternal 
and perinatal morbidity and mortality, accounting a 0.7 mater-
nal deaths per 100,000 live births.3 This syndrome is thought to 
be a consequence of abnormalities in the maternal vessels sup-
plying the placenta, leading to poor placental perfusion and 
release of factors causing widespread endothelial dysfunction 
with multiorgan system clinical features.4 The clinical findings 
of PE can therefore manifest, as either a maternal syndrome 
(hypertension and proteinuria with or without other multisys-
tem abnormalities), or fetal syndrome as fetal growth restric-
tion (FGR).5 This latter, though, is not exclusively observed in 
gestational hypertension (GH) or PE, and can be a complica-
tion of normotensive pregnancies.
Although the causes of PE are unknown, the origin of the 
condition is recognized as lying in the placenta. Shallow 
endovascular cytotrophoblast invasion in the spiral arteries 
and endothelial cell dysfunction are two key features in the 
pathogenesis of PE.6 Placental ischemia is thought to develop 
as a result of this abnormal cytotrophoblastic invasion; this 
has been proposed as leading to release of placental factors 
and imbalance of angiogenic factors, causing the widespread 
endothelial dysfunction.4,7–9
G-Protein coupled receptor (GPCR) kinase 2 (GRK2) rep-
resents an important regulator of cell functions by means of 
phosphorylative events on activated GPCR leading to desensi-
tization.10 GRK2 was first identified for its ability to phospho-
rylate and mediate desensitization of βAR, and its transgenic 
overexpression causes βAR desensitization and impaired βAR 
mediated increase in cardiac contractility. Recently, its ability 
to recognize and phosphorylate many more substrates has been 
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Background
G-Protein coupled receptor kinase 2 (GrK2) represents a regulator 
of cell function in different cardiovascular conditions, including 
high blood pressure. The relationship between elevated GrK2 levels 
and impaired vasorelaxant responses is causative of hypertension 
through the increase in vascular resistances. The aim of this study is to 
ascertain if this feature is present in the fetal placental vasculature of 
pregnancies complicated by hypertensive disorders.
Methods
We have assessed GrK2 levels in the umbilical arteries (Ua) of 21 
preeclamptic or gestational hypertensive and 23 normotensive 
women at time of delivery.
results
GrK2 levels were increased in the hypertensive group (0.83 ± 0.14 
vs. 0.48 ± 0.06 densitometry units; P < 0.05). GrK2 levels were in 
correlation and in linear regression with systolic, diastolic, and  
mean arterial pressure (P < 0.05, r2 = 0.12, r2 = 0.11, r2 = 0.12). 
correlations did not reach a significant value for other clinical 
parameters such as gestational age at birth, umbilical artery 
pulsatility index, maternal proteinuria, and neonatal birth weight. 
Out of the 21 hypertensive women, 7 who developed a  
preeclampsia associated with early preterm delivery (before  
34 weeks) had a significantly lower GrK2 levels compared  
to the remaining 14 (0.51 ± 0.12 vs. 1.08 ± 0.20 densitometry  
units, P < 0.05).
conclusions
We conclude that elevated GrK2 levels in the umbilical vasculature 
is correlated to elevated blood pressure levels, with a likely 
compensatory rather than causative role since the lack of protective 
effect of elevated GrK2 levels may negatively affect the outcome of 
the hypertensive state.
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described, leading to a scenario of interactions within the cell 
that appears to extend its role beyond receptor desensitization.
Increased levels of GRK2 are a hallmark of different cardio-
vascular conditions, including high blood pressure. In par-
ticular, GRK2 is increased in both experimental and human 
hypertension.11 Vascular smooth muscle cells restricted 
overexpression of GRK2 in transgenic mice causes the devel-
opment of hypertension and hypertension induced cardiac 
hypertrophy.12
The close relationship between elevated GRK2 levels and 
impaired vasorelaxant responses is therefore thought to be 
causative in hypertension through the increase in vascular 
resistances. Interestingly, this association is also present in other 
conditions characterized by increased blood pressure such as 
portal hypertension.13 It is therefore possible to suppose that 
this feature is also present in the vasculature of the placenta of 
pregnancies complicated with hypertensive disorders.
To follow this lead, we have assessed GRK2 levels in the vas-
culature of umbilical arteries (UA) of preeclamptic or gesta-
tional hypertensive women.
Methods
Design and study population. In a 2-year observation period 
(January 2008–December 2009) we enrolled 23 normoten-
sive pregnant women with no history of GH and 21 women 
with pregnancies complicated by hypertension, of which 13 
patients with PE and 8 with GH, consecutively admitted at 
the High Risk Pregnancy Unit, Department of Obstetrics and 
Gynecology of the University of Naples Federico II. We also 
enrolled five women with FGR, in absence of any increased 
blood pressure, since in this group, FGR is obviously not related 
to blood pressure. All patients provided written informed con-
sent prior the inclusion in the study. The study was approved 
by the University ethical committee and it conforms with the 
principles outlined in the Declaration of Helsinki.
GH was defined as the occurrence of a diastolic blood pres-
sure ≥90 mm Hg on at least two occasions 4 h apart, developing 
after 20 weeks of gestation in previously normotensive women 
in the absence of significant proteinuria. PE was defined as the 
occurrence of GH with proteinuria of 300 mg or more in 24 h 
or two readings of at least 2+ on dipstick analysis of midstream 
or catheter urine specimens if no 24-h collection is available. 
Superimposed PE on chronic hypertension (history of hyper-
tension before conception or the presence of hypertension at 
the booking visit before 20 weeks of gestation in the absence of 
trophoblastic disease), was defined by the presence of signifi-
cant proteinuria (as defined above) after 20 weeks of gestation.4 
The diagnosis of FGR was made according to the following cri-
teria: ultrasound measurement of the fetal abdominal circum-
ference below the 10th centile and UA pulsatility index above 
the 95th centile.14 The systolic and diastolic pressure values 
reported were collected at the time of the caesarean section.
As an outcome for PE we used the gestational age at birth. We 
divided the PE group in those with an early delivery (Early PE) 
when gestational age at birth was <34 weeks or a late delivery 
(Late PE), when gestational age at birth was >34 weeks.15,16
UA sampling and GRK2 evaluation. After elective or emergency 
Caesarean section, UA segments of 2–3 cm were collected by the 
dissection of Wharton’s jelly, frozen and stored at −80 °C until 
the day of the assay. On a following day, samples were dissolved 
in radio immunoprecipitation assay-sodium dodecyl sulfate 
buffer (50 mmol/l Tris-HCl (pH 7,5), 150 mmol/l NaCL, 1% 
NP-40, 0,25% deoxycholate, 9,4 mg/50 ml sodium orthovanad-
ate, 20% sodium dodecyl sulfate) to obtain the overall extract.17 
Samples were analyzed by western blot (WB). Proteins were 
electrophoresed by sodium dodecyl sulfate/polyacrylamide 
gel electrophoresis and transferred to nitrocellulose. GRK2 
was detected with a specific primary antibody 1:1,000 (Santa 
Cruz Biotechnology, Santa Cruz, CA) followed by incuba-
tion with an anti-mouse HRP-conjugated secondary antibody 
1:2,000 (Santa Cruz Biotechnology) as appropriate, and stand-
ard chemiluminescence (Reinassance, NEN). Densitometry 
analysis of digitalized autoradiographies was performed using 
a dedicated software (Image QuaNT Molecular Diagnostic; GE 
Healthcare Europe, Milan, Italy). GRK2 expression was cor-
rected by actin expression (corrected densitometry units).
β-adrenergic receptors (β-AR) radioligand binding. Since 
increased GRK2 associates with β-AR downregulation and 
desensitization, we assessed β-AR density exposed on uterine 
arteries. Membrane fractions obtained as previously described18 
were used for β-AR radioligand binding studies with the 
nonselective β-AR antagonist ligand [125I]-Cyanopindolol. 
Maximal binding was measured using a saturating amount 
of [125I]- Cyanopindolol on 25 μg membrane protein. Binding 
was allowed to occur for 1 h at 37 °C, as described previously.18 
Inclusion of 10 µmol/l alprenolol defined nonspecific binding. 
This analysis was performed for 7 patients with complicated 
pregnancies and 11 patients with normal pregnancies.
Statistical analysis. Statistical analysis was performed using 
SPSS 13.0 (SPSS, Chicago, IL). Values are given as the mean 
± s.e. Chi-square test was performed for categorical variables 
while an ANOVA test was used for comparison of means val-
ues of the three groups. For the continues variables a Pearson’s 
correlation and a linear regression analysis were considered. 
All the analyses were performed using a two-sided model, con-
sidering a normal distribution as appropriate. The P value less 
than 0.05 was considered statistically significant.
Fetus–maternal outcome parameters considered for the 
analysis were: gestational age at delivery, proteinuria, birth 
weight, and UA pulsatility index.
results
clinical characteristics
All the women were white. Out of 21 women with hyper-
tensive pregnancies, 3 of them had a chronic hypertension. 
Overall, 11 women developed PE (7 with an associated FGR), 
7 women developed GH (4 with an associated FGR). Clinical 
characteristics of normotensive and complicated pregnancies 
are depicted in Tables 1 and 2. The two groups were compara-
ble for anamnestic and physical characteristics. Women with 
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hypertension in pregnancy had a significant obstetric/clini-
cal history associated with the conditions. All patients were 
not in labour at the time of recruitment and at delivery and all 
patients delivered by elective or emergency caesarean section.
grk2 levels in normotensive and hypertensive pregnancies
GRK2 levels in the hypertensive group were higher when com-
pared either with the normotensive group (0.83 ± 0.14 vs. 0.48 
± 0.06 densitometry units; P < 0.05) or with the FGR group 
(0.83 ± 0.14 vs. 0.48 ± 0.06 vs. 0.39 ± 0.16 densitometry units; 
P < 0.05; Figure 1). FGR pregnancies did not differ in GRKs 
levels with normotensive group.
As a functional correlation of increased GRK2 levels, we also 
observed β-AR downregulation, as shown by lower density 
of β-AR in the hypertensive group (N = 11) when compared 
with the normotensive group (N = 7) (7.73 ± 1.36 vs. 20.96 ± 
7.57 pmol/μg, P < 0.05; Figure 2).
In the study population, GRK2 levels were in correlation 
(P < 0.05, Pearson’s test) and in linear regression with  systolic, 
diastolic, and mean arterial pressure (P < 0.05) (Figure 3). 
table 1 | anamnestic and physical characteristics of study population
Characteristics
mean (s.e.)/n (%) PE/GH Early PE Late PE/GH FGR Normotensive P values
Women 21 7 14 5 23
maternal age (years) 33 (1) 30 (3) 32 (3) 28 (3) 32 (1) NS
Weight (kg) 66 (3) 68 (7) 65 (4) 56 (2.7) 63 (2) NS
height (m) 1.6 (0) 1.6 (0) 1.6 (0) 1.6 (0) 1.6 (0) NS
BmI (kg/m2) 26 (6) 26 (7) 24 (5) 21 (1) 24 (1) NS
Nulliparous 18 (86) 7 (100) 11 (79) 5 (100) 20 (87) NS
Smokers 0 (0) 0 (0) 0 (0) 1(20) 1 (4) NS
Preexisting clinical 
conditionsa
4 (19) 1 (14) 3 (21) 0 (0) 0 (0) NS
Previous complicated 
pregnanciesb
2(9) 2 (29) 0 (0) 0 (0) 2 (9) NS
BMI, body mass index; Early PE, PE with delivery occurred <34 weeks; FGR, fetal growth restriction; GH, gestational hypertension; Late PE, PE with delivery occurred >34 weeks;  
PE, preeclampsia.
aChronic hypertension, kidney diseases, thrombophilia. bIntrauterine fetal death, preeclampsia, gestational hypertension, HELLP syndrome, abruptio placentae, preterm delivery.
table 2 | clinical details and outcome of study population
Characteristics 
mean (s.e.)/n (%) PE/GH Early PE Late PE/GH FGR Normotensive
Women 21 7 14 5 23
Systolic blood pressure 
(mm hg)
149 (4)*,** 149 (8)*,** 149 (4)*,** 115 (4) 115 (3)
Diastolic blood pressure 
(mm hg)
94 (2)*,** 91 (4)*,** 96 (2)*,** 72 (8) 74 (2)
Proteinuria (mg/24 h) 1,356 (480)*,** 1,771 (1223)*,** 1,148 (420)*,** 160 (40) 110 (4)
Gestational age at 
delivery (weeks)
34 (1)* 31 (1)* 36 (1)* 33 (4)* 39 (0)
Birth weight (g) 1,833 (199) 1,104 (147)* 2,198 (235)* 1,402 (296)* 3,010 (91)
Obstetric complicationsa 1 (0) 1 (0) 0 (0) 0 (0) 0 (0)
Early PE, PE with delivery occurred <34 weeks; FGR, fetal growth restriction; GH, gestational hypertension; Late PE, PE with delivery occurred >34 weeks; PE, preeclampsia.
aabruptio placentae (n = 1).
*P < 0.05 vs. normotensive group, **P < 0.05 vs. FGR.
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Figure 1 | Densitometry analysis of WB from Ua of different groups. GrK2 
data were corrected by those of actin and expressed as densitometry units. 
Data are expressed as means ± s.e. of GrK2 levels in each group. (*P < 0.05 
vs. normotensive). cDU, corrected densitometry units; FGr, fetal growth 
restriction; GrK2, G-protein coupled receptor kinase 2; Ua, umbilical arteries; 
WB, western blot.
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Interestingly, correlations did not reach a significant value for 
other clinical parameters such as gestational age at delivery, 
UA pulsatility index, proteinuria, and birth weight.
On the contrary, in the hypertensive group, GRK2 levels pre-
dicted Early PE (7 women, 33%). Indeed, GRK2 levels in this 
subgroup were lower when compared with women with Late 
PE or GH (n = 14) (0.51 ± 0.12 vs. 1.08 ± 0.20 densitometry 
units, P < 0.05) (Figure 4).
discussion
This study is the first report to describe a difference in the 
GRK2 levels in UA of pregnant women affected by hyperten-
sive disorders. Our results are the first of this kind, also because 
the expression of the kinase in the umbilical vasculature was 
never demonstrated before. In fact, it was previously described 
that the myometrium expresses GRK2, and that this levels are 
increased during physiological pregnancy.,19–21 To the best 
of our knowledge, our study is the first to associate increased 
GRK2 levels in the UA and GH.
Our results suggest that GRK2 might play a functional 
role of in the umbilical vasculature. First of all, the increased 
GRK2 are accompanied by the reduced number of β-AR on 
UA. A similar result is found in the vasculature of in essential 
hypertension,22 where this finding has been causally related to 
the increase in vascular resistances. Indeed, it has been dem-
onstrated that increased GRK2 levels depress vasodilatation 
through phosphorylative events on GPCRs, increase vascular 
resistance and therefore blood pressure.12,23 Another possi-
ble causal mechanism derives from recent literature showing 
that increased GRK2 can inhibit AKT and endothelial nitric 
oxide synthase activity in sinusoidal hepatic capillaries causing 
increased vascular resistance in the liver and, as a consequence, 
portal hypertension.13 In fact, a recent study demonstrated 
that the best independent predictor for maternal and fetal 
complications in a population of 526 high-risk primigravidas 
was total vascular resistance calculated at 24 weeks gestation.24 
Based on previous report, we felt that our findings allow to 
speculate that also in GH, increased levels of GRK2 are causa-
tive of elevated UA resistances.
To test this hypothesis, we assessed whether GRK2 and 
parameters of UA resistances (UA pulsatility index) correlate. 
Unexpectedly, we did not find this correlation, indicating that 
GRK2 cannot be causative of increases in UA resistances.
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Figure 3 | Linear regression analysis of parameters of blood pressure and 
GrK2 expression. (a) Linear regression analysis of systolic blood pressure and 
GrK2 expression (r2 = 0.12, P < 0.05); (b) Linear regression analysis of diastolic 
blood pressure and GrK2 expression (r2 = 0.11, P < 0.05). (c) Linear regression 
analysis of mean arterial pressure and GrK2 expression (r2 = 0.12, P < 0.05). 
GrK2, G-protein coupled receptor kinase 2.
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Figure 4 | GrK2 levels of women with Early PE and Late PE or Gh. Data are 
expressed as means ± s.e. densitometry units (*P < 0.05). cDU, corrected 
densitometry units; Early PE, PE with delivery occurred <34 weeks; GrK2, 
G-protein coupled receptor kinase 2; Gh, gestational hypertension; 
Late PE, PE with delivery occurred >34 weeks; PE, preeclampsia.
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Figure 2 | β-ar density. Data are expressed as means ± s.e. of β-ar 
densitometry units (*P < 0.05). β-ar, β-adrenergic receptors.
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Therefore, if not causative, the increase in GRK2 in the 
UA can then be a consequence of increased blood pressure, 
to compensate for the excessive vascular tension. Support to 
this second hypothesis derives from the finding that, within 
the PE group, those patients with lower levels of GRK2 in the 
UA presented with a worse outcome, as they had to deliver 
at an earlier gestational age. In this light, the observed lower 
levels of expression of GRK2 in UA of Early PE women 
might be considered as the lack of a protective mechanism. 
Accordingly, effects of GRK2 on β-AR sensitivity and den-
sity can be considered protective rather than causative for 
 hypertensive states.
Our data, therefore, suggest that the increase in GRK2 levels 
in the UA might play a protective role, rather than a causal one. 
If this is the case, the potential mechanism may be identified 
in the metabolic effect of the kinase. Indeed, we have recently 
demonstrated that GRK2 reduces glucose uptake25 and adeno-
sine triphosphate consumption, placing the cell in a low energy 
state that might favor cell survival in stress condition.26
The function of the β-AR has been investigated in pregnancy, 
but its significance in UA is controversial.27–29 It has been 
argued that the adrenergic dysfunction in PE could be related 
to β-AR signaling.29 Nevertheless, a supposed signaling altera-
tion has not been further investigated. Increased GRK2 levels 
are an important signaling regulator which can favour cAMP 
independent, β-Arrestin dependent pathways in response to 
β-AR stimulation.30 GRKs have been found to be also involved 
in the mechanism of myometrial uterine contractions in vitro 
and in experimental animal models.20,21 These findings show 
that the myometrium in labour presents increased GRK2 local-
ization on cell membrane, as a consequence of intense activa-
tion of myometrium GPCRs, such as the histamine receptor 
H1. Our data are original towards this previous finding since 
we studied UA, representing a different histological entity from 
the maternal myometrium. Also, in our group all the women 
were not in labour; considering these evidences, it is unlikely 
that the above mentioned GRK associated mechanism could be 
a confounding factor for our findings.
FGR, GH, and PE have common pathogenetic features.31 
In this study, FGR pregnancies do not present differences in 
GRK2 levels. This could be related to the exclusive association 
between GRK2 and elevated blood pressure levels, and there-
fore adds more to the protective role of GRK2 in PE.
study limitation
The most important limitation of the study is the small sam-
ple size and the heterogeneity of the women recruited. A larger 
number is necessary to assess the maternal response to hyper-
tension and developing of PE, as it would be testing GRK2 lev-
els in maternal blood. In fact, it has been previously reported a 
correlation between lymphocytes GRK2 isolated from periph-
eral blood sampling and tissue GRK2.32 Also, we have explored 
fetal rather than the maternal placental vasculature, which has 
otherwise been extensively reported in literature to be associ-
ated with incomplete spiral artery remodeling and inadequate 
blood supply in PE.33GRK2 regulation can help understand-
ing the biology of the UA and the mechanisms of hypertension 
in pregnancy, which still remain to be clarified. It is necessary 
to relate this protein either to the endothelial dysfunction 
and the release of vasoconstrictive factors or to a subsequent 
fetal mechanism to contrast the increased placental arteries 
resistance.
GRK2 has not been investigated in the maternal lymphocytes 
of serum blood. Longitudinal observations along gestation 
would help to study it as tool for diagnostic screening or inno-
vative therapeutic purposes.
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